药物诱导的泰罗基因流失的原因,第二部分
Donglin Zhang1, Charlotte LaSenna1, Bridget E Shields1
1Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison.
Cutis
|March 13, 2024
概括
药物诱导的头发流 (TE),头发脱落的常见原因,可以是可逆的. 识别和停止罪祸首药物,如抗凝剂和抗高血压剂是管理的关键.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 泰洛根流水 (TE) 是与药物相关的脱发 (脱发症) 的常见原因.
- 鉴定TE的特定药物触发因素可能是具有挑战性的,因为脱发的发作延迟.
- 药物诱导的TE通常是无痕的,并且在识别并停止治疗致病剂后可逆.
研究的目的:
- 专注于抗凝剂和抗高血压药物作为药物诱导TE的潜在触发因素.
- 为了解决特定药物类别引起的脱发管理提供见解.
主要方法:
- 文献综述侧重于药物诱导的端原流水.
- 分析与抗凝血剂和抗高血压药物相关的案例研究和临床数据.
- 讨论药物诱导的脱发症的诊断挑战和管理策略.
主要成果:
- 抗凝固剂和抗高血压药物被确定为药物诱导的TE的常见罪祸首.
- 脱发的临床表现延迟使病因诊断复杂化.
- 停止侵扰药物的治疗是可逆性脱毛的主要治疗方法.
结论:
- 准确识别诱发药物对于管理telogen effluvium至关重要.
- 抗凝固药和抗高血压药在出现不明原因脱发的患者中需要仔细考虑.
- 及时停止使用相关药物有助于头发的再生和脱发的解决.
相关概念视频
01:06Multipotency and Niche of Bulge Stem Cell
3.6K
A hair follicle or HF is a small part of the skin that produces the hair shaft. Paul Gerson Unna was the first to observe a bulge in the human hair follicle's outer root sheath (ORS). The bulge is present between the sebaceous gland and the arrector pili muscle and is the niche for hair follicle stem cells (HFSCs). The bulge is also a niche for melanocyte stem cells, and their loss results in graying of hair. The HFSCs express Sox9 and Lhx2, which help them maintain stemness and prevent...
3.6K
01:24Mania and Antimanic Drugs: Overview
176
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
176
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:23Antidepressant Drugs: MAOIs and Other Agents
228
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
228
01:30Electroconvulsive Therapy
39
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
39
01:26Psychosis: Goals of Pharmacotherapy
127
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
127